title: Management of low-stage nonseminomatous germ cell tumors of the testis.
abstract: Testicular cancer has become one of the most curable of all solid neoplasms. High cure rates associated with modern treatment regimens for low-stage testis cancer have resulted in a shift in focus toward reducing morbidity of potentially toxic treatment regimens.
authors.affiliation: Brigham and Women's Hospital, Harvard Medical School, Boston, Mass., USA.
authors.forename: G S
authors.initials: GS
authors.lastname: Steele
authors.forename: J P
authors.initials: JP
authors.lastname: Richie
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018237:Germinoma / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D008207:Lymphatic Metastasis; D008297:Male; D009367:Neoplasm Staging / Q000379:methods; D009919:Orchiectomy / Q000379:methods; D011379:Prognosis; D013736:Testicular Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*